Earnings before interest, taxes, depreciation, and amortization

IPL Plastics Inc. Reports Second Quarter 2020 Financial Results

Retrieved on: 
Tuesday, August 11, 2020

Adjusted Free Cash Flow increased by $18.3 million from $9.4 million for Q2 2019 to $27.7 million for Q2 2020.

Key Points: 
  • Adjusted Free Cash Flow increased by $18.3 million from $9.4 million for Q2 2019 to $27.7 million for Q2 2020.
  • Results for Q2 2020, as measured by Adjusted EBITDA, were impacted by COVID-19 and the associated containment measures which had largely been implemented globally as the Company entered the quarter.
  • We believe that the presentation of these financial measures enhance an investors understanding of our financial performance and financial condition.
  • The Company believes that the presentation of these financial measures enhances an investors understanding of its financial performance and financial condition.

Osmotica Pharmaceuticals plc Reports Second Quarter 2020 Results and Provides Business Updates

Retrieved on: 
Tuesday, August 11, 2020

Net loss for the second quarter of 2020 was $13.0 million, compared to a net loss of $124.9 million in the second quarter of 2019.

Key Points: 
  • Net loss for the second quarter of 2020 was $13.0 million, compared to a net loss of $124.9 million in the second quarter of 2019.
  • Adjusted EBITDA for the second quarter of 2020 was $2.3 million, compared to Adjusted EBITDA of $14.5 million for the second quarter of 2019.
  • Adjusted EBITDA is reconciled from the net loss as determined under GAAP in the attached table Osmotica Pharmaceuticals plc GAAP to Non-GAAP Reconciliations.
  • As previously announced, Osmotica management will host its second quarter 2020 conference call and provide a business update as follows:

XP Inc. Reports 2Q20 Financial Results

Retrieved on: 
Tuesday, August 11, 2020

Certain of the financial information as of and for the periods ended December 31, 2019, 2018 and 2017 has been derived from audited financial statements and all other financial information has been derived from unaudited interim financial statements.

Key Points: 
  • Certain of the financial information as of and for the periods ended December 31, 2019, 2018 and 2017 has been derived from audited financial statements and all other financial information has been derived from unaudited interim financial statements.
  • This release includes our Floating Balance, Adjusted Gross Financial Assets, Adjusted EBITDA and Adjustments to Reported Net Income, which are non-GAAP financial information.
  • The non-GAAP financial information is presented for informational purposes and to enhance understanding of the IFRS financial statements.
  • The non-GAAP measures should be considered in addition to results prepared in accordance with IFRS, but not as a substitute for, or superior to, IFRS results.

Pacific Ethanol Reports Second Quarter 2020 Results

Retrieved on: 
Tuesday, August 11, 2020

Our strong second quarter financial results, including net income of $14.6 million and Adjusted EBITDA of $28.8 million, were driven by our diversified product portfolio and expanded production of high quality alcohol, said Mike Kandris, Pacific Ethanols Co-CEO.

Key Points: 
  • Our strong second quarter financial results, including net income of $14.6 million and Adjusted EBITDA of $28.8 million, were driven by our diversified product portfolio and expanded production of high quality alcohol, said Mike Kandris, Pacific Ethanols Co-CEO.
  • Financial Results for the Three Months Ended June 30, 2020 Compared to 2019
    Net sales were $212.1 million, compared to $346.3 million.
  • Pacific Ethanols subsidiary, Kinergy Marketing LLC, markets all ethanol and high-quality alcohol products for Pacific Ethanols plants as well as for third parties.
  • Actual results may differ materially from Pacific Ethanols current expectations depending upon a number of factors affecting Pacific Ethanols business.

SUMR Brands Reports Second Quarter Results

Retrieved on: 
Tuesday, August 11, 2020

WOONSOCKET, R.I., Aug. 11, 2020 (GLOBE NEWSWIRE) -- SUMR Brands ("SUMR Brands" or the "Company") (NASDAQ: SUMR), a global leader in premium infant and juvenile products, today announced financial results for the second quarter ended June 27, 2020.

Key Points: 
  • WOONSOCKET, R.I., Aug. 11, 2020 (GLOBE NEWSWIRE) -- SUMR Brands ("SUMR Brands" or the "Company") (NASDAQ: SUMR), a global leader in premium infant and juvenile products, today announced financial results for the second quarter ended June 27, 2020.
  • Gross profit for the second quarter of 2020 was $14.0 million versus $14.8 million in 2019, while gross margin rose to 36.7% in 2020 versus 32.0% last year.
  • General and administrative expenses (G&A) were $6.7 million in the second quarter of 2020 versus $8.5 million in the second quarter of 2019, declining to 17.6% of net sales from 18.4% last year.
  • Adjusted EBITDA, as defined in the Companys credit agreements, for the second quarter of 2020 was $4.3 million versus $2.4 million for the second quarter of 2019, and Adjusted EBITDA as a percent of net sales was 11.4% in the second quarter of 2020 versus 5.3% last year.

Ra Medical Systems Reports 2020 Second Quarter Financial Results

Retrieved on: 
Tuesday, August 11, 2020

Net revenue from the vascular segment for the second quarter of 2020 was $0.1 million, compared with $0.4 million for the second quarter of 2019.

Key Points: 
  • Net revenue from the vascular segment for the second quarter of 2020 was $0.1 million, compared with $0.4 million for the second quarter of 2019.
  • Total cost of revenue for the second quarter of 2020 was $1.2 million, compared with $2.7 million for the second quarter of 2019.
  • Research and development expenses for the second quarter of 2020 were $2.0 million, compared with $1.0 million for the second quarter of 2019.
  • Adjusted EBITDA for the second quarter of 2020 was negative $8.4 million, compared with negative $7.8 million for the second quarter of 2019.

VitalHub Reports Positive EBITDA of 26% or $705,901 on Revenues of $2,748,895 for Q2 2020

Retrieved on: 
Tuesday, August 11, 2020

EBITDA for the six months ended June 30, 2020 was $693,211 as compared to $904,640 for the six months ended June 30, 2019.

Key Points: 
  • EBITDA for the six months ended June 30, 2020 was $693,211 as compared to $904,640 for the six months ended June 30, 2019.
  • Adjusted EBITDA for the six months ended June 30, 2020 was $1,036,551 as compared to $1,209,290 for the six months ended June 30, 2019.
  • The ACV of recurring revenue at June 30, 2020 was $7,491,841 as compared to $5,321,119 at June 30, 2019, an increase of 29%.
  • The Company defines acquisition recurring revenues as gross recurring revenues of the companies acquired at the time of acquisition and organic revenues as revenue over and above the acquisition recurring revenues.

The LGL Group Reports Second Quarter 2020 Results

Retrieved on: 
Tuesday, August 11, 2020

The LGL Group, Inc. (NYSE American: LGL) (the Company or LGL), announced its financial results for the three and six months ended June 30, 2020.

Key Points: 
  • The LGL Group, Inc. (NYSE American: LGL) (the Company or LGL), announced its financial results for the three and six months ended June 30, 2020.
  • SECOND QUARTER RESULTS In 2020, LGLs second quarter revenues decreased $779,000, or 9.9%, to $7.1 million compared to $7.8 million for the corresponding quarter in 2019.
  • Adjusted EBITDA was $0.3 million in the second quarter of 2020 versus $1.0 million in the second quarter of 2019.
  • EARNINGS PER SHARE Diluted earnings per share from ongoing operations, during the second quarter were $0.05 per share in 2020 as compared to $0.19 per share in the second quarter of 2019.

BIOREM Reports 2020 Second Quarter Results

Retrieved on: 
Tuesday, August 11, 2020

Biorem's revenues for the second quarter were $5.9 million a 14% decrease over the previous quarter and on par with the $5.9 million of revenues reported in the same quarter in 2019.

Key Points: 
  • Biorem's revenues for the second quarter were $5.9 million a 14% decrease over the previous quarter and on par with the $5.9 million of revenues reported in the same quarter in 2019.
  • Gross profit for the quarter was $1.4 million or 23.9% of revenue compared to $1.3 million of gross profit representing 22.5% of revenue recorded during the second quarter of 2019.
  • Ebitda for the quarter was $504,000 compared to $295,000 of ebitda in the second quarter of 2019.
  • This results in the BIOREM order backlog being $30.9 million on June 30, 2020.

RADA Reports Record Q2/2020 Results and Increases 2020 Revenue Guidance to $70 Million

Retrieved on: 
Tuesday, August 11, 2020

NETANYA, Israel, Aug. 11, 2020 /PRNewswire/ -- RADA Electronic Industries Ltd. (NASDAQ: RADA) announced today its financial results for the three and six months periods ended June 30, 2020.

Key Points: 
  • NETANYA, Israel, Aug. 11, 2020 /PRNewswire/ -- RADA Electronic Industries Ltd. (NASDAQ: RADA) announced today its financial results for the three and six months periods ended June 30, 2020.
  • 2020 revenue guidance increased to over $70 million, implying over 58% growth year-over-year, with continued sequential revenue growth throughout the remainder of the year
    US manufacturing facility at full operation to supply US market demand.
  • We reported Adjusted EBITDA of $1.7 million in the quarter, which was more than double that of the first quarter."
  • As of June 30, 2020, RADA had net cash and cash equivalents of $29.5 million compared to $13.8 million as of year-end 2019.The inventory level has increased to $26.5 million from $17.2 million as at the end of 2019.